Pallister-Killian mosaic syndrome

Active Research Protocols

  1. 08-C-0078 – A Phase II Trial of Pemetrexed (Alimta [Registered Trademark]) Combined with Sirolimus (Rapamycin, Rapamune [Registered Trademark]) in Subjects with Relapsed or Refractory NSCLC
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014